Your browser doesn't support javascript.
loading
Enhanced serum immunoglobulin G clearance in myotonic dystrophy-associated hypogammaglobulinemia: a case series and review of the literature.
Sasson, Sarah C; Corbett, Alastair; McLachlan, Andrew J; Chen, R; Adelstein, S A; Riminton, Sean; Limaye, Sandhya.
Afiliación
  • Sasson SC; Nuffield Department of Medicine, Experimental Medicine Division, University of Oxford, Level 5, John Radcliffe Hospital, Oxford, OX3 9DU, UK. ssas7805@med.usyd.edu.au.
  • Corbett A; Department of Neurology, Concord Hospital, Sydney, Australia.
  • McLachlan AJ; Sydney Pharmacy School, University of Sydney, Sydney, Australia.
  • Chen R; Immunopathology Laboratory, Department of Clinical Immunology, Royal Prince Alfred Hospital, Sydney, Australia.
  • Adelstein SA; Immunopathology Laboratory, Department of Clinical Immunology, Royal Prince Alfred Hospital, Sydney, Australia.
  • Riminton S; Sydney Medical School, University of Sydney, Sydney, Australia.
  • Limaye S; Sydney Medical School, University of Sydney, Sydney, Australia.
J Med Case Rep ; 13(1): 338, 2019 Nov 20.
Article en En | MEDLINE | ID: mdl-31744540
BACKGROUND: Myotonic dystrophy type 1 is an autosomal dominant disorder characterized by muscle weakness, myotonia, cataracts, and cardiac conduction defects; it is associated with expansions of cytosine-thymine-guanine repeats in the myotonic dystrophy protein kinase. Hypogammaglobulinemia is a lesser known association of myotonic dystrophy type 1 and the underlying pathogenesis of immunoglobulin G depletion remains unclear. CASE PRESENTATION: Here we report a kindred of two members (a 62-year-old white woman and a 30-year-old white man; mother and son) with myotonic dystrophy type 1-associated hypogammaglobulinemia associated with altered intravenous immunoglobulin elimination kinetics and reduced half-life. There was no history of systemic immunosuppression or renal or gastrointestinal protein loss in either patient, and no underlying case for a secondary immunodeficiency could be found. One patient required fortnightly intravenous immunoglobulin to maintain adequate trough immunoglobulin G levels. CONCLUSIONS: Ongoing study of myotonic dystrophy type 1-associated hypogammaglobulinemia using contemporary tools of genomic medicine may help to further delineate the pathogenesis of this entity.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Inmunoglobulina G / Núcleo Familiar / Inmunoglobulinas Intravenosas / Agammaglobulinemia / Madres / Distrofia Miotónica Tipo de estudio: Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: J Med Case Rep Año: 2019 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Inmunoglobulina G / Núcleo Familiar / Inmunoglobulinas Intravenosas / Agammaglobulinemia / Madres / Distrofia Miotónica Tipo de estudio: Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: J Med Case Rep Año: 2019 Tipo del documento: Article